Table 1 Characteristics of the included studies
Study | Region | Group | Number of patients | Age, years (median or mean) | Sex (M/F) | BMI (mean or median) | ASA score (mean or median) | Tumor stage (T1 or lower) /T2/T3/T4 | Diversion type ileal conduit/Neobladder/ continent cutaneous | Rate of neobladder (%) |
|---|---|---|---|---|---|---|---|---|---|---|
Catto et al., 2022 [14] | UK | RARC/ORC | 161/156 | 69.3/68.7 | 128/33; 122/34 | NA | NA | 71/30/NA/NA 70/34/NA/NA | 142/NA/NA; 140/NA/NA | NA |
Vejlgaard et al., 2022 [20] | Denmark | RARC/ORC | 25/25 | 70/67 | 18/7; 20/5 | 27.3/26.9 | 2.12/2 | 9/13/3/NA 6/15/4/NA | 25/0/0; 25/0/0 | 0/0 |
Maibom et al., 2022 [16] | Denmark | RARC/ORC | 25/25 | 70/67 | 18/7; 20/5 | 27.3/26.9 | 2.12/2 | 9/13/3/NA 6/15/4/NA | 25/0/0; 25/0/0 | 0/0 |
Mastroianni et al., 2022 [15] | Italy | RARC/ORC | 58/58 | 64/66 | 44/14; 40/18 | 26/26 | 2.19/2.07 | 11/45/2/0; 12/44/2/0 | NA/46/0; NA/42/NA | 79/72 |
Khan et al., 2020 [21] | UK | RARC/ORC | 20/20 | 68/68 | 17/3; 18/2 | 27.50/26.99 | 1.85/1.85 | 11/3/6/0; 14/0/4/2 | 18/2/0; 17/3/0 | 10/15 |
Venkatramani et al., 2020 [22] | USA | RARC/ORC | 150/152 | 70/67 | 126/24; 128/24 | 27.8/28.2 | NA | 48/82/6/4; 51/81/16/4 | 113/36/1; 122/30/0 | 24/20 |
Bochner et al., 2018 [23] | USA | RARC/ORC | 60/58 | 66/65 | 51/9; 42/16 | 27.9/29 | 2.73/2.84 | 35/8/12/5; 32/7/15/4 | 27/33/0; 23/32/3 | 55/55 |
Parekh et al., 2018 [4] | USA | RARC/ORC | 150/152 | 70/67 | 126/24; 128/24 | 27.8/28.2 | NA | 48/82/6/4; 51/81/16/4 | 113/36/1; 122/30/0 | 24/20 |
Khan et al., 2016 [24] | UK | RARC/ORC | 20/20 | 68.6/66.6 | 17/3; 18/2 | 27.5/27.4 | 1.85/1.85 | 11/3/6/0; 14/0/4/2 | 18/2/0; 17/3/0 | 10/15 |
Bochner et al., 2015 [25] | USA | RARC/ORC | 60/58 | 66/65 | 51/9; 42/16 | 27.9/29 | 2.73/2.84 | 35/8/12/5; 32/7/15/4 | 27/33/0; 23/32/3 | 55/55 |
Messer et al., 2014 [26] | USA | RARC/ORC | 20/20 | 69.5/64.5 | 18/2; 16/4 | 27.6/28.3 | 3.0/3.0 | 7/3/3/7; 12/1/2/5 | 19/1/0; 18/2/0 | 5/10 |
Parekh et al., 2013 [27] | USA | RARC/ORC | 20/20 | 69.5/64.5 | 18/2; 16/4 | 27.6/28.3 | 3.0/3.0 | 7/3/3/7; 12/1/2/5 | 19/1/0; 18/2/0 | 5/10 |
Nix et al., 2010 [19] | USA | RARC/ORC | 21/20 | 67.4/69.2 | 14/7; 17/3 | 27.5/28.4 | 2.71/2.70 | 6/12/3/0; 5/14/1/0 | 14/7/0; 14/6/0 | 33/30 |